Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-05

FDA Approved: ESTAZOLAM — Supplemental Application (Novitium Pharma LLC)

View source ↗

Summary

FDA approves a supplemental application for Estazolam by Novitium Pharma LLC under ANDA074826.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estazolam (Estazolam)

Snippet

SUPPL AP for ESTAZOLAM (ESTAZOLAM)